Indication
ATryn is indicated for the prophylaxis of venous thromboembolism in surgery of patients with congenital antithrombin deficiency. ATryn is normally given in association with heparin or low molecular weight heparin.
Loading your page…
Loading your page…
Antithrombin III Deficiency
Marketing Authorisation Holder: Laboratoire Francais du Fractionnement et des Biotechnologies
EMA Authorisation: 28/07/2006
INN: antithrombin alfa
AI Drug & Interaction Analysis
Free account required
Ask Osler about ATryn: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.